These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Site-directed mutagenesis of alpha II spectrin at codon 1175 modulates its mu-calpain susceptibility. Stabach PR; Cianci CD; Glantz SB; Zhang Z; Morrow JS Biochemistry; 1997 Jan; 36(1):57-65. PubMed ID: 8993318 [TBL] [Abstract][Full Text] [Related]
25. Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay. Saitsu H; Tohyama J; Kumada T; Egawa K; Hamada K; Okada I; Mizuguchi T; Osaka H; Miyata R; Furukawa T; Haginoya K; Hoshino H; Goto T; Hachiya Y; Yamagata T; Saitoh S; Nagai T; Nishiyama K; Nishimura A; Miyake N; Komada M; Hayashi K; Hirai S; Ogata K; Kato M; Fukuda A; Matsumoto N Am J Hum Genet; 2010 Jun; 86(6):881-91. PubMed ID: 20493457 [TBL] [Abstract][Full Text] [Related]
26. Case of infantile onset spinocerebellar ataxia type 5. Jacob FD; Ho ES; Martinez-Ojeda M; Darras BT; Khwaja OS J Child Neurol; 2013 Oct; 28(10):1292-5. PubMed ID: 22914369 [TBL] [Abstract][Full Text] [Related]
27. Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells. Glantz SB; Cianci CD; Iyer R; Pradhan D; Wang KK; Morrow JS Biochemistry; 2007 Jan; 46(2):502-13. PubMed ID: 17209560 [TBL] [Abstract][Full Text] [Related]
28. Cerebellar ataxias: β-III spectrin's interactions suggest common pathogenic pathways. Perkins E; Suminaite D; Jackson M J Physiol; 2016 Aug; 594(16):4661-76. PubMed ID: 26821241 [TBL] [Abstract][Full Text] [Related]
29. Beta-III spectrin mutation L253P associated with spinocerebellar ataxia type 5 interferes with binding to Arp1 and protein trafficking from the Golgi. Clarkson YL; Gillespie T; Perkins EM; Lyndon AR; Jackson M Hum Mol Genet; 2010 Sep; 19(18):3634-41. PubMed ID: 20603325 [TBL] [Abstract][Full Text] [Related]
30. Screening of the SPTBN2 (SCA5) gene in German SCA patients. Zühlke C; Bernard V; Dalski A; Lorenz P; Mitulla B; Gillessen-Kaesbach G; Bürk K J Neurol; 2007 Dec; 254(12):1649-52. PubMed ID: 17940722 [TBL] [Abstract][Full Text] [Related]
31. β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicity. Denha SA; Atang AE; Hays TS; Avery AW Sci Rep; 2022 Feb; 12(1):1726. PubMed ID: 35110634 [TBL] [Abstract][Full Text] [Related]
32. β-III-spectrin spinocerebellar ataxia type 5 mutation reveals a dominant cytoskeletal mechanism that underlies dendritic arborization. Avery AW; Thomas DD; Hays TS Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9376-E9385. PubMed ID: 29078305 [TBL] [Abstract][Full Text] [Related]
33. Targeted deletion of betaIII spectrin impairs synaptogenesis and generates ataxic and seizure phenotypes. Stankewich MC; Gwynn B; Ardito T; Ji L; Kim J; Robledo RF; Lux SE; Peters LL; Morrow JS Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6022-7. PubMed ID: 20231455 [TBL] [Abstract][Full Text] [Related]
34. An alpha II spectrin mutant peptide with unstable scaffold structure and increased sensitivity to calpain cleavage. Skrzymowska J; Zalas M; Goszczyński TM; Miazek A Biochem Biophys Res Commun; 2021 Dec; 581():68-73. PubMed ID: 34656850 [TBL] [Abstract][Full Text] [Related]
35. Increased actin binding is a shared molecular consequence of numerous spinocerebellar ataxia mutations in β-III-spectrin. Atang AE; Keller AR; Denha SA; Avery AW bioRxiv; 2023 Apr; ():. PubMed ID: 36865188 [TBL] [Abstract][Full Text] [Related]
36. Critical roles of αII spectrin in brain development and epileptic encephalopathy. Wang Y; Ji T; Nelson AD; Glanowska K; Murphy GG; Jenkins PM; Parent JM J Clin Invest; 2018 Feb; 128(2):760-773. PubMed ID: 29337302 [TBL] [Abstract][Full Text] [Related]
37. Spectrins and human diseases. Li S; Liu T; Li K; Bai X; Xi K; Chai X; Mi L; Li J Transl Res; 2022 May; 243():78-88. PubMed ID: 34979321 [TBL] [Abstract][Full Text] [Related]
38. Novel drug discovery platform for spinocerebellar ataxia, using fluorescence technology targeting β-III-spectrin. Rebbeck RT; Andrick AK; Denha SA; Svensson B; Guhathakurta P; Thomas DD; Hays TS; Avery AW J Biol Chem; 2021; 296():100215. PubMed ID: 33839680 [TBL] [Abstract][Full Text] [Related]
39. AlphaII-spectrin is an in vitro target for caspase-2, and its cleavage is regulated by calmodulin binding. Rotter B; Kroviarski Y; Nicolas G; Dhermy D; Lecomte MC Biochem J; 2004 Feb; 378(Pt 1):161-8. PubMed ID: 14599290 [TBL] [Abstract][Full Text] [Related]
40. Structural basis for high-affinity actin binding revealed by a β-III-spectrin SCA5 missense mutation. Avery AW; Fealey ME; Wang F; Orlova A; Thompson AR; Thomas DD; Hays TS; Egelman EH Nat Commun; 2017 Nov; 8(1):1350. PubMed ID: 29116080 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]